Table 1 The top 10 significant down- and up-regulated genes associated with lymph node metastasis or TNM stages

Lymph node metastasis

 Down-regulated

7SK

1.92E−54

1.62E−50

SNORA73B

2.30E−47

1.29E−43

SNORD17

2.50E−44

1.20E−40

SCARNA6

1.57E−42

5.85E−39

SCARNA5

1.80E−42

6.05E−39

SCARNA10

4.91E−41

1.45E−37

MSTN

3.65E−39

9.44E−36

SCARNA7

7.12E−37

1.68E−33

SCARNA13

3.84E−36

7.73E−33

RNU4-1

3.91E−36

7.73E−33

 Up-regulated

NNAT

2.37E−89

7.97E−85

LRRC38

1.32E−68

2.23E−64

VSX2

1.85E−55

2.07E−51

AC087257.2

1.84E−52

1.24E−48

LINC01433

3.82E−43

1.61E−39

FAM205C

7.49E−37

1.68E−33

AL161668.1

1.56E−35

2.77E−32

RTP1

1.65E−34

2.64E−31

GSG1L2

1.11E−31

1.44E−28

CALB1

4.30E−31

5.16E−28

TNM stages

 Down-regulated

7SK

6.74E−31

6.13E−28

SNORA73B

1.76E−27

1.26E−24

SNORD17

1.51E−25

9.39E−23

SCARNA5

5.95E−25

3.63E−22

SCARNA6

2.75E−24

1.62E−21

SCARNA10

1.35E−23

7.42E−21

MSTN

1.70E−23

8.96E−21

SCARNA7

2.81E−22

1.26E−19

RNU4-1

6.97E−21

2.79E−18

RNU4-2

1.26E−20

4.94E−18

 Up-regulated

PPIAP46

1.92E−100

6.46E−96

HNRNPA1P52

4.95E−96

8.32E−92

LRRC38

3.92E−92

4.39E−88

AC087257.2

1.53E−81

1.28E−77

VSX2

1.90E−76

1.28E−72

PSG11

2.93E−58

1.64E−54

FAM205C

6.97E−55

3.35E−51

FXNP2

1.45E−53

6.09E−50

MARCH4

1.61E−45

6.02E−42

RTP1

5.41E−45

1.82E−41